These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8619565)

  • 1. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
    Barry AL; Brown SD; Novick WJ
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
    Barry AL; Brown SD; Fuchs PC
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
    Bell SM; Gatus BJ; Pham JN
    Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
    Skulnick M; Small GW; Lo P; Patel MP; Porter CR; Low DE; Matsumura S; Mazzulli T
    J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Apr; 38(4):898-900. PubMed ID: 8031069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
    Karlowsky JA; Jones ME; Draghi DC; Sahm DF
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniae.
    Albrecht WE; Papasian CJ; Bamberger DM; Fiorella R; Riddell SW
    J Clin Microbiol; 1997 Apr; 35(4):985-7. PubMed ID: 9157169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
    Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
    J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
    Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
    Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
    Balcabao IP; Aguilar L; Martín M; García Y; Dal-Ré R; Prieto J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2904-6. PubMed ID: 9124866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.